News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
66,350 Results
Type
Article (6826)
Company Profile (15)
Press Release (59509)
Section
Business (17026)
Career Advice (83)
Deals (2797)
Drug Delivery (13)
Drug Development (14874)
Employer Resources (16)
FDA (2017)
Job Trends (2406)
News (35846)
Policy (5360)
Tag
Academia (399)
Alliances (5592)
Alzheimer's disease (167)
Approvals (2034)
Bankruptcy (27)
Best Places to Work (2229)
Breast cancer (24)
Cancer (199)
Career advice (80)
CAR-T (16)
Cell therapy (43)
Clinical research (10587)
Collaboration (77)
COVID-19 (2052)
C-suite (18)
Data (218)
Diagnostics (404)
Drug discovery (12)
Earnings (5772)
Employer resources (15)
Events (8275)
Executive appointments (41)
FDA (2159)
Funding (56)
Gene therapy (31)
GLP-1 (75)
Government (1838)
Healthcare (2237)
Infectious disease (2128)
Inflammatory bowel disease (31)
Influenza (31)
IPO (1202)
Job creations (321)
Job search strategy (75)
Layoffs (76)
Legal (528)
Lung cancer (16)
Lymphoma (15)
Manufacturing (38)
Medical device (441)
Medtech (441)
Mergers & acquisitions (1624)
Metabolic disorders (32)
Multiple sclerosis (11)
Neuroscience (199)
NextGen: Class of 2025 (412)
Non-profit (365)
Northern California (160)
Obesity (19)
Opinion (36)
Ovarian cancer (12)
Patents (21)
People (4734)
Phase I (3801)
Phase II (4583)
Phase III (3694)
Pipeline (90)
Policy (17)
Postmarket research (427)
Preclinical (1626)
Press Release (20)
Radiopharmaceuticals (15)
Rare diseases (29)
Real estate (510)
Regulatory (3447)
Reports (12)
Research institute (411)
RSV (42)
Southern California (128)
Startups (323)
United States (1827)
Vaccines (687)
Weight loss (17)
Date
Today (16)
Last 7 days (67)
Last 30 days (234)
Last 365 days (3855)
2025 (234)
2024 (3910)
2023 (4542)
2022 (7866)
2021 (8864)
2020 (7241)
2019 (3443)
2018 (2591)
2017 (2680)
2016 (2544)
2015 (3091)
2014 (2271)
2013 (1806)
2012 (2044)
2011 (2220)
2010 (2018)
Location
Africa (170)
Alabama (15)
Asia (4530)
Australia (727)
California (331)
Canada (162)
China (34)
Connecticut (20)
Delaware (15)
Europe (11134)
Florida (52)
Georgia (31)
Illinois (18)
Indiana (28)
Japan (15)
Maryland (261)
Massachusetts (324)
Minnesota (12)
New Jersey (264)
New York (140)
North Carolina (62)
Northern California (160)
Pennsylvania (132)
South America (113)
Southern California (128)
Texas (40)
Washington State (37)
66,350 Results for "rational vaccines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Announce Collaboration to Develop Herpes Vaccines in China
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. announced they have reached an agreement to jointly develop, manufacture, and commercialize live vaccines against herpes simplex viruses.
October 30, 2023
·
2 min read
Earnings
Sanofi Earnings Driven by Dupixent, New RSV Vaccine as Hunt for Deals Continues
Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.
January 30, 2025
·
2 min read
·
Dan Samorodnitsky
Vaccines
Moderna Nabs Another $590M from HHS for mRNA-Based Bird Flu Vaccines
The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready before bird flu strains currently circulating in the wild and on farms can potentially cause human outbreaks.
January 21, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Arrakis Therapeutics Unveils Data for its Lead, Rationally Designed, RNA-Targeted Small Molecule (rSM) Drug Program Demonstrating Disease-Modifying Binding to RNA to Treat Myotonic Dystrophy
December 4, 2024
·
5 min read
Rational’s Experimental Herpes Vaccine Shows Preclinical Promise
Rational Vaccines said findings from a pilot study showed that RVX201 led to a reduction in recurrent genital lesions when compared to gD2-alum/MPL vaccine in animal studies.
July 8, 2022
·
2 min read
·
Alex Keown
RSV
FDA Committee Calls For More Research After Moderna’s RSV Vaccine Safety Issues
Following news of RSV lower respiratory tract infections in infants immunized with Moderna’s investigational RNA vaccines, FDA advisors said the trial investigators should continue the study, while keeping an eye out for further safety signals.
December 13, 2024
·
3 min read
·
Tristan Manalac
Government
Trump Picks Vaccine Critic Weldon to Lead CDC, Makary for FDA Head
Career conservative and former congressman Dave Weldon will, if confirmed, act as director of the Centers of Disease Control and Prevention, where his anti-vaccine views will mesh with those of selected Department of Health and Human Services head Robert F. Kennedy Jr.
November 25, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine
January 20, 2025
·
10 min read
Vaccines
UK Patent Win Over GSK Boosts Pfizer in Global RSV Vaccine Fight
A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, positioning both companies to compete for that market and laying down a marker for ongoing legal clashes in other parts of the world.
November 20, 2024
·
4 min read
·
Nick Paul Taylor
Vaccines
5 Late-Stage mRNA Vaccines to Watch
The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the market for cancer, influenza and more.
September 16, 2024
·
5 min read
·
Ben Hargreaves
1 of 6,635
Next
